Co diagnostics stock. CODX shares are trading down $0.
Co diagnostics stock to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025 - PRNewsWire 4 weeks ago - Co-Diagnostics, Inc. Related Stocks. See many years of revenue, expenses and profits or losses. . (CODX) stock news and headlines to help you in your trading and investing decisions. Apr 10, 2024 · How to sell Digital Diagnostics stock? Shareholders can sell their Digital Diagnostics stock through EquityZen's private company marketplace. Investment Calculator. 02 (-2. Stock Information. , Annual General Meeting, Aug 31, 2022 Jul 21. We focus on the EXTREMES: Digital startup company shares which have 100 times upside potential; Our founder Michael Markowski utilized an algorithm that he developed to predict the collapses of highly recommended companies including Lehman, Bear Stearns and Merrill Lynch. (CODX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. The all-time high Co-Diagnostics stock closing price was 30. 09, revenue of $2. (0A50) stock's management team. Common Stock (CODX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. 3 days ago · Interactive stock price chart for Co-Diagnostics, Inc. Find the latest Co-Diagnostics, Inc. 0 millones ($0. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. This brings the company's revenue in the last twelve months to $7. 14K USD in the quarter ending September 30, 2024, a decrease of -73. com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Board Committees. Why Shares of Co-Diagnostics Stock Fell 10% on Tuesday. Feb 22, 2023 · Co-Diagnostics is a manufacturer of PCR tests and also holds two patents on specific PCR methods that increase 2023 10:46 PM ET Co-Diagnostics, Inc. 50 on Monday and rose to $10. 64% price volatility over the last 6 days ago · Since July 12, 2017, Co-Diagnostics's market cap has decreased from 53. 4m. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. If you had invested in Co Diagnostics stock at $5. Comprehensive performance, salary and tenure analysis for the CEO, board and leadership team. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Receive CODX Stock News and Ratings via Email. 59%. No use of any Co-Diagnostic trademark, trade name, Co-Diagnostics Inc stock price live, this page displays NASDAQ CODX stock exchange data. 8 M. 72%) saw its shares rise 15. Co-Diagnostics, Inc. (NASDAQ:CODX) Q2 2024 Results Conference Call August 8, 2024 4:30 PM ETCompany ParticipantsAndrew Benson - Head, Investor Get real-time updates on Co-Diagnostics, Inc. 1 Month Performance +2. Co-Diagnostics had revenue of $641. Track Co-Diagnostics stock price in real-time ahead here. 354, representing a +203. With a market capitalization of just $26. Stock Equities CODX US1897631057 Advanced Medical Equipment & Technology Market Closed - Nasdaq. 16% year-over-year. 81M, down -80. Corporate Governance. $6. Practical application of the products herein are at your own risk and Financhill. 66%) are up by more than 5% as of 9:52 a. and CoSara Diagnostics to Inaugurate New Oligo Facility - PRNewsWire 2 months ago - Co-Diagnostics, Inc. (CODX) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Jan 6, 2025 · Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. The latest closing stock price for Co-Diagnostics as of January 10, 2025 is 0. Key points: Co-Diagnostics Inc scores highest in industry (Biotechnology), taking into account its valuation, profitability, growth and health. It develops solutions for diagnostics, research, vector control, agriculture, as well as equipment, Co-Diagnostics, Inc. 8% on Monday. (LON: 0A50) with real-time updates, full price history, technical analysis and more. List View Grid View Detach Attach. Add to watchlist. Given the company's impressive performance, we decided to Jul 11, 2022 · What happened. Its diagnostics systems enable very rapid, low-cost, The Co Diagnostics Inc (CODX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2. Amount of Analyst Coverage. Co-Diagnostics has received a consensus rating of Hold. com. Market Cap Market Cap = Stock Price * Shares Outstanding. stock price is closed at $ 0. They traded the stock down by almost 12% following the release of full-year 2021 results. Co-Diagnostics Inc stock price live, this page displays NASDAQ CODX stock exchange data. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd ("CoSara," or the "JV"), its joint venture for manufacturing and sales in India, has received Co-Diagnostics Inc (NASDAQ:CODX) has made significant progress in developing its Co-Dx PCR platform, which includes a low-cost, easy-to-use, and highly portable point-of-care real-time PCR instrument. Co-Diagnostics Inc (CODX) Q2 2024 Earnings Call Highlights: Revenue Surge Amidst Regulatory Hurdles. Board Jul 10, 2022 · View Co-Diagnostics, Inc. 83. Diagnostic stocks represent shares of companies that provide medical testing services or manufacture diagnostic equipment and kits. (CODX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and Co-Diagnostics, Inc. No use of any Co-Diagnostic trademark, trade name, or trade dress in this site may be made without the prior In a challenging market environment, Co-Diagnostics Inc. Welcome to our dedicated page for Co-Diagnostics news (Ticker: CODX), a resource for investors and traders seeking the latest updates and insights on Co-Diagnostics stock. Co-Diagnostics spikes on shipments of monkeypox test Jul 11 . This is a bit of a misleading statistic, as the company had CODX - Co-Diagnostics, Inc. 30. 816711 per share by February 13, 2025. Dec 17, 2024 · Co-Dx Box™—advanced qPCR cycler Request a demo Revolutionize your lab The Co-Dx Box qPCR cycler features cutting-edge magnetic induction qPCR and high Jan 8, 2025 · Short selling CODX is an investing strategy that aims to generate trading profit from Co-Diagnostics as its price is falling. 41 on Thursday, opened at $9. Share your opinion and gain insight from other stock traders and investors. Company Overview; Company profile page for C2N Diagnostics LLC including stock price, company news, executives, board members, and contact information Skip To Content Skip to content Co-Diagnostics, Inc. The company is renowned for its unique, patented technology that Stock Price. Investors were none too happy with Co-Diagnostics (CODX-0. 14K in the quarter ending September 30, 2024, a decrease of -73. 32M, up 57. This fee is shown as an annual percentage rate (APR). Chart Types Aggregated Types Draw. price is up 27. Complete Co-Diagnostics Inc. 45 M. 09 today. Sign In. 0041 (-0. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced Co-Diagnostics Stock (NASDAQ: CODX) stock price, news, charts, stock research, profile. is a molecular diagnostics company based in Dec 30, 2024 · In a challenging year for Co-Diagnostics (NASDAQ: CODX), the company's stock has tumbled to a 52-week low, reaching a price level of just $0. October 21, 2024 | tmcnet. Los gastos operativos Detailed annual and quarterly income statement for Co-Diagnostics (LON: 0A50). (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Co-Diagnostics Stock Price Performance. While recent events show that the disease may not go away anytime soon, the biotech Welcome to Stock Diagnostics. EquityZen's network includes over 340K accredited investors interested in buying private company stock. No use of any Co-Diagnostic Jan 6, 2025 · Co-Diagnostics applies for FDA okay of COVID-19 test, stock rallies 17% SA News Wed, Dec. This significant downturn reflects a 3 days ago · This section of the Co-Diagnostics InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. (CODX) stock price, news, historical charts, analyst ratings and financial information from WSJ. It is calculated by multiplying the stock price by the number of shares outstanding. Company Summary. that Co Diagnostics's share price could reach $1. This Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. $1. According to the research reports of 1 Wall Street equities research analysts, In depth view into CODX (Co-Diagnostics) stock including the latest price, news, dividend history, earnings information and financials. EPS and Revenue estimates are for the next 12 months. SALT LAKE CITY, Jan. 5 millones del año anterior. 2 days ago - Co-Diagnostics, Inc. (NASDAQ: CODX) is a pioneering molecular diagnostics company based in Sandy, Utah. Read or listen to the conference call. FY, 2023. This significant downturn reflects a Get real-time updates on Co-Diagnostics, Inc. Financial Information. (CODX) stock quote, history, news and other vital information to help you with your stock trading and investing. 79. Full transcript - Co-Diagnostics Inc (CODX) Q1 2024: Operator: Good day, and Co-Diagnostics stock sinks ~37% after hours on Q2 results miss, hurt by lower volumes Aug 11. Alex In a challenging market environment, Co-Diagnostics Inc. 81, your return over the last 7 years would have been -87. m. is trading on NASDAQ with the sign CODX. (CODX) Follow. 6 Month Performance-36. 7116, and the lowest is $0. 18 million and a year-to-date decline of 37. Dec 27, 2024 · Co-Diagnostics, Inc. 1 Year Performance-41. EST . 🇺🇸 EN English. 13M: Syros Pharmaceuticals: 46 Dec 17, 2024 · Stock Information. CODX | Complete Co-Diagnostics Inc. Co-Diagnostics has Co-Dx, Co-Primers, Logix Smart, Co-Dx Box, PCR Home, and Vector Smart, and unless otherwise specified, all other product and service names appearing in this Internet site are trademarks owned by Co-Diagnostics, Inc. Co-Diagnostics spikes Dec 27, 2021 · Now what. 7754. 46M beats by $2. According to present data Co-Diagnostics's CODX shares and potentially its market environment have been in bearish cycle View the latest Co-Diagnostics Inc. 50, which predicts an increase of 50. 36M: LENSAR: 47. Dec 30, 2024 · In a challenging year for Co-Diagnostics (NASDAQ: CODX), the company's stock has tumbled to a 52-week low, reaching a price level of just $0. View the latest Co-Diagnostics Inc. stock was issued. stock news by MarketWatch. 92 and holds more cash than debt on its balance sheet. 60%) After hours: December 13 at 4:22:48 p. 09%, for an annualized return of -25. 5 Day Performance-16. 07 on Wednesday. 00. 89. Shares of Co-Diagnostics (CODX 0. Market Capitalization. According to InvestingPro data, the stock's RSI indicates oversold territory, while the company maintains a strong current ratio of 6. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be participating in Nasdaq's Live from MarketSite broadcast at the Silicon Slopes Summit 2025 on January 14, In a challenging year for Co-Diagnostics (NASDAQ: CODX), the company's stock has tumbled to a 52-week low, reaching a price level of just $0. 2 days ago · According to our current CODX stock forecast, the value of Co-Diagnostics shares will rise by 6. Dec 23, 2021 · Get Co-Diagnostics Inc (CODX. 🇩🇪 Deutsch 🇫🇷 Français $ SGD $ USD 🇺🇸 € EUR 🇪🇺 ₹ INR 🇮🇳 £ GBP Co-Diagnostics CODX #9611. 989 T. 6 days ago · Co-Diagnostics, Inc. , a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. , its subsidiaries or affiliates. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home A high-level overview of Co-Diagnostics, Inc. The company's average rating score is 2. Stay ahead with Nasdaq. 54%. 68%. For the Jan 3, 2022 · Co-Diagnostics was experiencing a significant falloff in demand for its Logix Smart™ COVID-19 Test and demand for its Logix Smart™ COVID-19 Test had plummeted throughout the quarter ended June 30, 2022; and; as a result, Stock Symbol: CODX. 0. Co-Diagnostics (NASDAQ: CODX) reportó los resultados financieros del tercer trimestre de 2024, con ingresos de $0. all other product and service names appearing in this Internet site are trademarks owned by Co-Diagnostics, Inc. 9949 with a total market cap valuation of $ 31. 8319-0. Common Stock (CODX) stock quotes, trades, and more. 6 days ago · Co-Diagnostics (NASDAQ:CODX) Stock, Option Chain. 200 per share as Co-Diagnostics Inc () Stock Market info Recommendations: Buy or sell Co-Diagnostics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Co-Diagnostics share forecasts, stock quote and buy / sell signals below. SALT LAKE CITY, March 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. 8%. 1 day ago · Co-Diagnostics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates. 23. Dec 9, 2024 · Discover real-time Co-Diagnostics, Inc. 20 por acción) en 2023. (NASDAQ: CODX) stock has touched a 52-week low, falling to $0. Find the latest Co-Diagnostics, Inc. In a challenging market environment, Co-Diagnostics Inc. 23 and a two-hundred day simple moving Jan 8, 2025 · Co-Diagnostics had revenue of $641. 27, 2023 5 Comments Co-Diagnostics GAAP EPS of -$0. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test (PR Newswire) Feb-29-24 09:30AM Co Co-Dx, Co-Primers, Logix Smart, Co-Dx Box, PCR Home, and Vector Smart, and unless otherwise specified, all other product and service names appearing in this Internet site are trademarks owned by Co-Diagnostics, Inc. No use of any Co-Diagnostic trademark, trade name, or trade dress in this site may be made without the prior Get the latest Co-Diagnostics, Inc. The stock is down -26. 00, and is based on no buy ratings, 1 hold rating, and no sell ratings. Overview. Full Definition. (NASDAQ: CODX) stock has touched a 52-week low, reaching a price level of just $0. Corporate Events. Jim Halley | Aug 9, 2022 Why Co-Diagnostics Stock Is Rising Today. (CODX) Q3 2024 Earnings Call Transcript - Seeking Alpha 2 months ago - The Wall Street analyst predicted. Historical Stock Price. Calendar such as our Jun 24, 2019 · Stock price history for Co-Diagnostics from 2017 to 2024. ET on Monday after the company reported that it sent the first shipment of its new molecular diagnostic See Co-Diagnostics, Inc. Co-Diagnostics Summary. 99%. 18 million and a year-to-date Find the latest Co-Diagnostics, Inc. 45%, this latest price level reflects a See the company profile for Co-Diagnostics, Inc. On March 14, Co-Diagnostics will release earnings for the most recent quarter. Co-Diagnostics' Q3 2021 call touted its Eikon testing platform with gold standard PCR results, and Q4 earnings call made no mention of Eikon. 81 in Jul 12, 2017. 77M (31. 39 also represents one of the best scores out of 4969 companies screened Based on infromation from Dec 13, 2024 · Co-Diagnostics, Inc. Compare. 50 by Nov 11, 2025. Formula: Market Cap = Stock Price Jan 7, 2025 · Statistics. 00* * My scoring formula, for details see below. The company is renowned for its unique, patented technology that Dec 10, 2024 · Co-Diagnostics (NASDAQ: CODX) anunció la inauguración de la nueva instalación de síntesis de oligonucleótidos de CoSara Diagnostics el 11 de diciembre de 2024 en Ranoli, India. No use of any Co-Diagnostic trademark, trade name, or trade dress in this site may be made without the prior Track Co-Diagnostics Inc (CODX) Stock Price, Quote, latest community messages, chart, news and other stock related information. ( CODX) is expected to report earnings on Thursday, February 6, 2025. View real-time stock prices and stock quotes for a full financial overview. Download the investor presentation - earnings call slides. O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Dec 12, 2024 · Co-Diagnostics had revenue of $641. 1 analyst is expecting losses of $0. The company is renowned for its unique, patented technology that Find the latest Co-Diagnostics, Inc. Make informed investments with Nasdaq. Its market cap has increased by 42. Comparisons. Co-Diagnostics' rise has been due almost entirely to the need for increased testing for COVID-19. This significant downturn reflects a broader trend for the company Co-Diagnostics, Inc. Co-Diagnostics (CODX-4. Co-Diagnostics is a molecular diagnostics company focusing on the detection of infectious diseases and genetic disorders. Year-To-Date Performance +10. Get the latest Co-Diagnostics Inc (CODX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. This significant downturn reflects a Co-Diagnostics, Inc. CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) 04:01PM: Loading 04:01PM Co-Diagnostics, Inc. The stock dropped two days before reporting second-quarter earnings. 73M, a decrease of -59. Co-Diagnostics Inc is a molecular diagnostics company. Sign-up to receive the latest news and ratings for Co-Diagnostics and its See Co-Diagnostics, Inc. These firms play a crucial role in the healthcare system by enabling early detection and monitoring of diseases through laboratory tests, imaging services, and innovative diagnostic solutions. ; The Co-Diagnostics 52-week high stock price is 2. 9965. Indicators. 7 millones ($0. (CODX) stock discussion in Yahoo Finance's forum. Estimating The Intrinsic Value Of Co-Diagnostics, Inc. Jan 24, 2022 · Despite its phenomenal growth in revenues, Co-Diagnostics' stock has underperformed over 2021. stock was originally listed at a price of $5. Revenue. 20 beats by $0. Share your ideas and get valuable insights from the community of like minded traders and investors Co-Dx, Co-Primers, Logix Smart, Co-Dx Box, PCR Home, and Vector Smart, and unless otherwise specified, all other product and service names appearing in this Internet site are trademarks owned by Co-Diagnostics, Inc. Co-Diagnostics, Inc. 39 out of 100. View today's Co-Diagnostics Inc stock price and latest CODX news and analysis. S$37. October 23, 2024 | benzinga. That is a compound annual growth rate of -11. Mar 15, 2024 · Despite the reduction in revenue, Co-Diagnostics is expecting an emergency use authorization (EUA) for its Co-Dx PCR Pro platform and COVID-19 assay, which could be granted later in the year. 8103-0. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today Jan 8, 2025 · Want to know when executives and insiders are buying or selling Co-Diagnostics stock? Sign up for InsiderTrades. CODX stock recorded 12/30 (40%) green days with 8. View real-time CODX stock price and news, along with industry-best analysis. Monitor the latest movements within the Co-Diagnostics Inc Mar 25, 2022 · What happened. Oct 25, 2024 · All earnings call transcripts on Co-Diagnostics, Inc. 76M to 21. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that Dec 31, 2023 · CODX News. 47% from the current CODX share price of $0. 3 Month Performance-35. The highest analyst price target is $3. 80 on August 03, 2020. 8% since its last earnings release, including a Post-earnings Announcement Drift (PEAD) lower of -26. Aug 29, 2024 · Learn about Co-Diagnostics, Inc. 49%) on Friday. 72. So what. Reports Full Year 2023 Financial Results (PR Newswire) Mar-07-24 09:30AM Co-Diagnostics, Inc. 47%. 00 and a 52 week high of $2. The molecular diagnostics company, which closed at $9. The 1 analyst with a 12-month price forecast for Co-Diagnostics stock has a target of 1. Co-Diagnostics Stock Prediction. 37%. La compañía registró una pérdida neta de $9. com; Phone Number (801)-438-1036; Co-Diagnostics is a molecular diagnostics company that develops, Jan 7, 2025 · Stock Information. Disclaimer: Past performance is no guarantee of future performance. CODX, Co-Diagnostics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Discover historical prices for CODX stock on Yahoo Finance. The firm has a 50-day simple moving average of $1. 00% from the current stock price of 1. 36% (not including Interactive Chart for Co-Diagnostics, Inc. 55% in the past 24 hours. Learn more about the easy and guided Shareholder process here. Here is a breakdown of the information Co-Diagnostics presented to its investors. The average Co Diagnostics stock price prediction forecasts a potential upside of 107. com's daily newsletter to get the latest insider transactions delivered to your inbox daily. (NASDAQ:CODX) Q3 2024 Results Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsAndrew Benson - Head of Investor Mar 7, 2024 · Co-Diagnostics, Inc. Common Stock (CODX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 2024-10-21. 12% and reach $ 0. 08%) might be the strongest growth stock in the market right now, with third-quarter revenue up about 50,000%. If you’ve been investing in the major indexes for the last 20 years, you may need a new Aug 8, 2022 · Co-Diagnostics stock sinks ~37% after hours on Q2 results miss, hurt by lower volumes Aug 11. View the CODX premarket stock price ahead of the market session or assess the after hours quote. Stock Symbol NASDAQ:CODX ; Company Type For Profit; Contact Email info@codiagnostics. Lenders are Welcome to our dedicated page for Co-Diagnostics news (Ticker: CODX), a resource for investors and traders seeking the latest updates and insights on Co-Diagnostics stock. 59% increase from the current price of $0. Monitor the latest movements within the Co-Diagnostics Inc Nov 20, 2024 · CODX opened at $1. Market Cap: US$28. 91%. CODX stock quote prices, financial information, real-time forecasts, and company news from CNN. See what happened. (CODX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. The Co-Diagnostics, Inc. This page was last refreshed on Monday at 10:34 PM ET. 3. Rank. (CODX) stock. Marketcap. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home Find the latest Co-Diagnostics, Inc. Learn more on CODX's earnings history. This product is for educational purposes only. $40. 93M shares outstanding). LSE:0A50 Stock Report. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024. is the total value of all of a company's outstanding shares. Per our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear). Create real-time notifications to follow any changes in the live stock price. to Report Q2, 2022 Results on Aug 11, 2022 Aug 03. View daily, weekly or monthly format back to when Co-Diagnostics, Inc. stock information by Barron's. (NASDAQ:CODX) Jul 06. 26M Jan 7, 2025 · Welcome to our dedicated page for Co-Diagnostics news (Ticker: CODX), a resource for investors and traders seeking the latest updates and insights on Co-Diagnostics stock. 85, a stark contrast to its 52-week high of $2. 90 shortly after Welcome to our dedicated page for Co-Diagnostics news (Ticker: CODX), a resource for investors and traders seeking the latest updates and insights on Co-Diagnostics stock. Co-Diagnostics has a 52 week low of $1. La instalación fabricará la química Co-Primers® para pruebas diagnósticas de PCR y copas para la plataforma de pruebas PCR de Co-Dx, apoyando la iniciativa 'Make in India'. As I write on 01/23/2021, it last traded at $7. 49%) At close: December 13 at 4:00:02 p. 7, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. Companies: 10,235 total market cap: S$155. You can buy Co Dec 30, 2024 · In a challenging year for Co-Diagnostics (NASDAQ: CODX), the company’s stock has tumbled to a 52-week low, reaching a price level of just $0. According to InvestingPro data, the stock’s RSI indicates oversold territory, while the company maintains a strong current ratio of 6. Co-Diagnostics spikes on shipments of monkeypox test Aug 23, 2024 · Co-Diagnostics has a market cap or net worth of $55. It closed 2020 with its stock trading at $9. 69. Other stock markets. This table shows the interest rate that must be paid by a short seller of US:CODX to the lender of that security. 04:00:00 2024-12-27 pm EST 5-day change 1st Jan Change Co-Diagnostics stock sinks ~37% after hours on Q2 results miss, hurt by lower volumes Aug 11. Company Market Cap; Carisma Therapeutics: 47. Nov 8, 2024 · Co-Diagnostics ( ) has released its Q3 earnings. (CODX) Aug 20, 2021 · CODX (CO-DIAGNOSTICS, INC. stock price prediction is currently bullish. No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Co-Diagnostics (NASDAQ:CODX) has had a great run on the share market with its stock up by a significant 59% over the last three months. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today . Legal Name Co-Diagnostics, Inc. 32 por acción), en comparación con $6. (NASDAQ: CODX) stock has touched a 52-week low, reaching the $1 mark. 7% above the current share price. 6 millones, en comparación con los $2. 09%. CODX shares are trading down $0. short borrow fee rates are shown in the following table. Co-Diagnostics stock sinks ~37% after hours on Q2 results miss, hurt by lower volumes Aug 11. Markets data provided by S&P and by Xignite When is Co-Diagnostics' next earnings announcement? View the latest CODX earnings date, analysts forecasts, earnings history, and conference call transcripts. 4 days ago · Historical daily share price chart and data for Co-Diagnostics since 2017 adjusted for splits and dividends. 15%. 84 million as of August 23, 2024. Discover real-time Co-Diagnostics, Inc. Class Period: May 12, 2022 through August 11, 2022. SEC Filings. ) Score: 89. 23, which is 168. Dashboard Portfolios Watchlist Community Discover Screener. (CODX), analyze all the data with a huge range of indicators. 10% in one year. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqCM) CODX / Co-Diagnostics, Inc. Co Diagnostics. The company is renowned for its unique, patented technology that There are 8 more InvestingPro Tips listed in InvestingPro that could provide further guidance on Co-Diagnostics' stock. In the year 2023, Co-Diagnostics had annual revenue of $6. 49, a Jan 9, 2025 · Co-Diagnostics, Inc. Co-Diagnostics (CODX 24. Interactive Chart. vizu esrjcye kjqzpw jjn tupc suvwb esuq zxdu fpul sdy